The stock has a 36-month beta value of 2.94. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for VANI is 29.93M, and at present, short sellers hold a 0.99% of that float. On June 04, 2025, the average trading volume of VANI was 85.30K shares.
VANI) stock’s latest price update
Vivani Medical Inc (NASDAQ: VANI)’s stock price has gone decline by -7.32 in comparison to its previous close of 1.23, zacks.com reported 2025-06-02 that VANI is set to spin off Cortigent, aiming to sharpen its focus on drug implants and unlock long-term value for both entities.
VANI’s Market Performance
Vivani Medical Inc (VANI) has seen a 0.00% fall in stock performance for the week, with a 9.62% gain in the past month and a 3.64% surge in the past quarter. The volatility ratio for the week is 6.16%, and the volatility levels for the past 30 days are at 3.31% for VANI. The simple moving average for the past 20 days is 3.68% for VANI’s stock, with a -3.74% simple moving average for the past 200 days.
VANI Trading at 7.02% from the 50-Day Moving Average
After a stumble in the market that brought VANI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -45.45% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at VANI starting from Williams Gregg, who purchase 6,836 shares at the price of $1.01 back on May 15 ’25. After this action, Williams Gregg now owns 13,838,490 shares of Vivani Medical Inc, valued at $6,904 using the latest closing price.
Williams Gregg, the Director of Vivani Medical Inc, purchase 3,499 shares at $1.01 during a trade that took place back on May 14 ’25, which means that Williams Gregg is holding 13,831,654 shares at $3,534 based on the most recent closing price.
Stock Fundamentals for VANI
Current profitability levels for the company are sitting at:
- -125.66 for the present operating margin
- 0.5 for the gross margin
The net margin for Vivani Medical Inc stands at -119.34. The total capital return value is set at -0.85. Equity return is now at value -117.76, with -53.23 for asset returns.
Based on Vivani Medical Inc (VANI), the company’s capital structure generated 0.62 points at debt to capital in total, while cash flow to debt ratio is standing at -1.13.
Currently, EBITDA for the company is -23.09 million with net debt to EBITDA at -0.24. When we switch over and look at the enterprise to sales, we see a ratio of 369.2. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.40.
Conclusion
To sum up, Vivani Medical Inc (VANI) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
